Avid Bioservices Inc (CDMO)

[PhoenixRising]

I was not here in 2002/3 but it seems so strange that PPHM went after such a niche market as many here agree with,only to find out AFTER? completion of Phase II they had to redo w/ dual catheters?Did the FDA require dual catheters during the current Phase II and then mandate dual catheters,or is PPHM snake-bit,so to speak? Then they complete Phase II AGAIN(and gain Phase III approval) only to stipulate that they would not move forward w/o a partner. Some have posted here it cost up to 60 million dollars to run those trials(I do not know that to be factual) but why glioblastoma(GBM) to begin with? It's a horrible thing but it is still considered a small market product/profit-wise...sadly. Dollars ARE the bottom line,IMO. I'm only asking because Cotara appears to be the topic du jour,if you will. PR